Abnormal DNA Repair
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects (NCT03012321) | Northwestern University | 2017-01-12 |
Track Abnormal DNA Repair automatically
Every clearance here is in the API, with alerts when new ones post.